Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, Capecitabine and Bevacizumab in Advanced Biliary Cancers
NCT01007552Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Dec 2009
- Primary completion
- May 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in gallbladder adenocarcinoma, cholangiocarcinoma (CCA), sponsored by Roswell Park Comprehensive Cancer Center. Started Dec 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
gallbladder adenocarcinomacholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT01007552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007552.